UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043139
Receipt number R000049076
Scientific Title Prognostic significance of sarcopenia in patients treated with surgery or radiotherapy for head and neck cancer: A meta-analysis
Date of disclosure of the study information 2021/02/01
Last modified on 2022/04/16 22:32:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prognostic significance of sarcopenia in patients treated with surgery or radiotherapy for head and neck cancer: A meta-analysis

Acronym

effect of sarcopenia on head and neck cancer treatment

Scientific Title

Prognostic significance of sarcopenia in patients treated with surgery or radiotherapy for head and neck cancer: A meta-analysis

Scientific Title:Acronym

sarcopenia and head and neck cancer

Region

Japan


Condition

Condition

head and neck cancer

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the prognostic impact of sarcopenia on head and neck cancer

Basic objectives2

Others

Basic objectives -Others

effect on oncologic outcomes

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overall survival

Key secondary outcomes

disease-specific survival, disease-free survival


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

studies regarding the effect of sarcopenia on treatment outcomes in head and neck cancer
Treatment for head and neck cancer is either curative intent surgery or radiotherapy.

Key exclusion criteria

studies investigating nasopharyngeal carcinoma or thyroid cancer
hazard ratios are not available
non-human studies
reviews
conference abstracts

Target sample size



Research contact person

Name of lead principal investigator

1st name takenaka
Middle name
Last name yukinori

Organization

Osaka university graduate school of medicine

Division name

department of otorhinolaryngology-head and neck surgery

Zip code

5650871

Address

2-2 yamadaoka, suita, osaka

TEL

+81-6-6879-3951

Email

ytakenaka@ent.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name takenaka
Middle name
Last name yukinori

Organization

Osaka university graduate school of medicine

Division name

department of otorhinolaryngology-head and neck surgery

Zip code

5650871

Address

2-2 yamadaoka, suita, osaka

TEL

+81-6-6879-3951

Homepage URL


Email

ytakenaka@ent.med.osaka-u.ac.jp


Sponsor or person

Institute

osaka university

Institute

Department

Personal name



Funding Source

Organization

self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

osaka university

Address

2-2 yamadaoka, suita, osaka

Tel

0662108290

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 01 Day


Related information

URL releasing protocol

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0259288

Publication of results

Unpublished


Result

URL related to results and publications

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0259288

Number of participants that the trial has enrolled

3233

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 02 Month 01 Day

Date of IRB

2021 Year 06 Month 01 Day

Anticipated trial start date

2021 Year 02 Month 01 Day

Last follow-up date

2021 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Literature search is to be done on 2/1/2021.
Statistical analyses is to be done by 6/1/2021.


Management information

Registered date

2021 Year 01 Month 26 Day

Last modified on

2022 Year 04 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049076


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name